Skip to content

Dual-Channel Structure-Aware Transformer Framework for Drug-Drug Interaction Prediction.

Sep 2026 · IEEE journal of biomedical and health informatics · Vol PP · 0 citations
Medicine

Abstract

Accurate prediction of drug-drug interactions (DDIs) is crucial for ensuring drug safety and supporting pharmaceutical development. Existing methods still face challenges in jointly modeling molecular structural information and biomedical semantic contexts. To address this issue, we propose DSAT-DDI, a Dual-channel Structure-Aware Transformer framework for DDI prediction. The core design of DSAT-DDI lies in incorporating structure-aware attention into both molecular and knowledge graph representation learning, enabling the model to capture local chemical environments and semantic neighborhoods while preserving global dependency modeling. In addition, a bidirectional cross-attention fusion mechanism is introduced to dynamically integrate molecular and biomedical representations and generate pair-aware drug embeddings. Experimental results on the DrugBank and KEGG datasets show that DSAT-DDI consistently outperforms representative molecular-based, knowledge graph-based, and multimodal baselines across multiple evaluation metrics. These results demonstrate the effectiveness of structure-aware attention and bidirectional cross-attention fusion for robust DDI prediction.

View source

Similar papers

Open access Sep 2026

Multiscale cross modal fusion and cascaded signal propagation for drug target interaction prediction

SF-DTI is a unified framework that integrates multi-encoder protein fusion, structure-semantic drug alignment, and progressive cross-modal refinement for DTI prediction and may support virtual screening, drug repositioning, and drug discovery.

Bo-Wen Wang, Xiao-Lan Xie, Hai-Tao Zou et al. · 0 citations
Open access Sep 2026

KGTC-DDA:Drug-disease association prediction based on parallel graph isomorphism and transformer networks with cross-attention

This work proposes Drug-disease association prediction model (KNN, GIN, Graph Transformer and Cross-attention, KGTC-DDA), a novel framework that combines Graph Isomorphism Networks (GIN), Graph Transformers, and cross-attention mechanisms for drug-disease association prediction.

Jia-Hao Chen, Zi Liu, Li-Yi Yu et al. · 0 citations
Sep 2026

FGMDTI: Fine-grained Multimodal Learning for Drug-Target Interaction Prediction via Bidirectional Cross-Attention.

Drug-target interaction (DTI) prediction is critical for drug discovery and repositioning. Existing methods often rely on coarse-grained representations and fail to capture the reciprocal nature of molecular recognition. We propose FGMDTI, a fine-grained multimodal framework that models bidirectional interactions betwe...

Meng-De Li, Chi Zhou, Wen-Bin Liu et al. · 0 citations
Sep 2026

MLI-DTA: An interpretable multimodal framework with multi-level interactions for drug-target affinity prediction.

MLI-DTA is proposed, a hierarchical multi-source feature fusion network based on multi-level attention that encodes both sequence and graph modalities of drugs and targets, and performs exceptionally well in the Davis and KIBA benchmarks.

Yu-Ning Liu, Guang-Ze Wang, Dan Liu et al. · 0 citations
Open access Sep 2026

Deciphering Mechanistic Signatures in Drug-Drug Interactions with Dual Topology Graphs

Drug-drug interactions (DDIs) represent a critical challenge in drug development and clinical practice, as they can lead to severe adverse effects, including toxicity and reduced therapeutic efficacy. Deep learning methods have shown promise in large-scale, rapid DDI prediction; however, current approaches suffer from...

Wen-Jian Ma, Xiang-Peng Bi, Hua-Sen Jiang et al. · 0 citations
Aug 2026

MMU-DPI: Enhancing Generalization in Drug-Protein Interaction Prediction through Multimodal Learning and a Label Mix Strategy.

Experimental results on multiple benchmark data sets demonstrate that MMU-DPI outperforms several state-of-the-art DPI prediction methods and indicate that MMU-DPI can serve as a useful computational tool for drug discovery.

Jia-Hao Wei, Tie Shen · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.